XRCC4 and neoplasm: Although our previous reports exhibited that the genic mutations at coding regions of XRCC4 were significantly related to poor overall survival (OS) and tumor recurrence-free survival (RFS) of hepatocarcinoma cases [20, 21], it is not still clear whether XRCC4 expression is an independent marker for hepatocarcinoma prognosis.